Clinical trial · Observational
Multi-Cancer Detection Observational Cohort Study
NCT06962995CI-TRIAL-00107446recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study assesses the incorporation of Multi-Cancer Detection (MCD) testing, designed to detect many types of cancer, into clinical practice to understand both its use and effect in real world practice conditions.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Blood Sample | Procedure | — | UNRESOLVED |
| Surveys | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Observational
- description
- Patients complete surveys and have their medical records reviewed on study. Patients may undergo blood or buccal swab and urine sample collection on study.
- interventionNames
- Procedure: Blood Sample
- Other: Surveys
Primary outcomes (4)
- measure
- Financial impact of MCD testing
- timeFrame
- Up to 5 years
- description
- Assessed by types of diagnostic studies ordered as a result of positive MCD test results (e.g., to establish or rule out a cancer diagnosis).
- measure
- Positive actionable MCD results
- timeFrame
- Up to 5 years
- description
- Assessed by the number of participants who receive positive MCD results
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 21 Years
Show eligibility criteria text
Inclusion Criteria: * Has Mayo Clinic medical record number * Has undergone (within last 6 months) or scheduled to undergo a multi-cancer detection test (MCD) as ordered by provider * Able to provide informed consent * ≥ 21 years old * Ability to provide blood sample Exclusion Criteria: * Individuals who have situations that would limit compliance with the study requirements * Institutionalized (i.e. Federal Medical Prison) * Known pregnancy (self-reported) * Currently undergoing active cancer treatment other than adjuvant hormone therapy * Invasive cancer diagnosis within the last 3 years
References
Publications (0)
Data not yet available
No reference posted for this study.